Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression

Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression

OBJECTIVE: To evaluate long-term safety and efficacy of esketamine nasal spray plus a new oral antidepressant (OAD) in patients with treatment-resistant depression (TRD). METHODS: This phase 3, open-label, multicenter, long-term (up to 1 year) study was conducted between October 2015 and October 201...

Full description

Bibliographic Details
Main Authors:	Wajs, Ewa, Aluisio, Leah, Holder, Richard, Daly, Ella J., Lane, Rosanne, Lim, Pilar, George, Joyce E., Morrison, Randall L., Sanacora, Gerard, Young, Allan H., Kasper, Siegfried, Sulaiman, Ahmad Hatim, Li, Cheng Ta, Paik, Jong Woo, Manji, Husseini, Hough, David, Grunfeld, Jennifer, Jeon, Hong Jin, Wilkinson, Samuel T., Drevets, Wayne C., Singh, Jaskaran B.
Format:	Article
Published:	Physicians Postgraduate Press 2020
Subjects:	R Medicine

Similar Items

Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant
by: Carol Jamieson, et al.
Published: (2023-05-01)

Overcoming the myths of esketamine administration: different and not difficult
by: Florian Buchmayer, et al.
Published: (2023-11-01)

A Meta-Analysis of the Antidepressant Responses in Pivotal Trials on Esketamine Nasal Spray and Atypical Antipsychotics
by: Wang L, et al.
Published: (2023-12-01)

Efficacy and Safety of Esketamine Combined with Antidepressants for Treatment-Resistant Depression: A Meta-Analysis
by: Liu P, et al.
Published: (2022-12-01)

Montgomery‐Åsberg Depression Rating Scale factors in treatment‐resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine
by: Stephane Borentain, et al.
Published: (2022-12-01)

Research advances in the clinical application of esketamine
by: Xiao‐Xi Zhang, et al.
Published: (2022-03-01)

Esketamine/ketamine for treatment-resistant depression
by: Acioly L.T. Lacerda
Published: (2020-05-01)

Intranasal esketamine and the dawn of precision psychiatry
by: Devon Watts, et al.
Published: (2021-07-01)

Treating with esketamine nasal, will increase blood pressure?
by: V. Rosello-Molina, et al.
Published: (2021-04-01)

The role of intranasal esketamine in treatment-resistant depression
by: A. Fraga, et al.
Published: (2021-04-01)

The use of ketamine and esketamine in psychiatry: now and beyond
by: Jose Carlos Appolinario, et al.
Published: (2022-10-01)

Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Plus a Newly Initiated Oral Antidepressant in Adult Patients with Treatment-Resistant Depression: A Randomized, Double-Blind, Multicenter, Active-Controlled Study Conducted in China and USA
by: Chen X, et al.
Published: (2023-03-01)

Intranasal Esketamine administration in catatonia: a case report.
by: J. Romay, et al.
Published: (2023-03-01)

How effective are ketamine or esketamine in treatment-resistant depression?
by: N. Veluri, et al.
Published: (2021-04-01)

Clinical efficacy and tolerability of Esketamine: a case series
by: C. Passani, et al.
Published: (2022-06-01)

Efficacy and safety of fixed doses of intranasal Esketamine as an add-on therapy to Oral antidepressants in Japanese patients with treatment-resistant depression: a phase 2b randomized clinical study
by: Nagahide Takahashi, et al.
Published: (2021-10-01)

Which component of TMS-induced electric field contributes to the antidepressant effects?
by: Bella B.B. Zhang, et al.
Published: (2023-01-01)

Esketamine reduces ischemia-reperfusion injury of skeletal muscle of rats
by: YUAN Peigen, CHEN Shunli, SHAN Yuanlu, XUE Binbin, YE Yuzhu, LIN Lina
Published: (2023-12-01)

Intranasal esketamine use in bipolar disorder: A case report
by: Courtney Skriptshak, PharmD, et al.
Published: (2021-07-01)

ANESTHETIC EFFECT OF PROPOFOL COMBINED WITH ESKETAMINE AND SUFENTANIL IN HYSTEROSCOPIC SURGERY
by: YAN Rubing, SUN Jingbo, HAN Shuai, SHI Jianwen, CHU Haichen, LIANG Yongxin
Published: (2023-06-01)

The Patient’s Perspective on the Effects of Intranasal Esketamine in Treatment-Resistant Depression
by: Maria Pepe, et al.
Published: (2023-10-01)

Safety and efficacy of esketamine for postoperative analgesia in pediatric patients with hypospadias
by: Yong Xu, et al.
Published: (2023-04-01)

Esketamine following transcranial magnetic stimulation for treatment resistant depression
by: Aliaa Al-Sabbagh, et al.
Published: (2022-09-01)

Esketamine Anesthetizes Mice With a Similar Potency to Racemic Ketamine
by: Xiaofan Ma, et al.
Published: (2023-02-01)

Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review
by: Fabrice Jollant, et al.
Published: (2023-02-01)

Bayesian network analysis of antidepressant treatment trajectories
by: Rosanne J. Turner, et al.
Published: (2023-05-01)

The cognitive effects of esketamine: what do we know so far?
by: M. Barbosa, et al.
Published: (2022-06-01)

Electroconvulsive therapy vs Esketamine among patients with Major Depressive Episode
by: M. D. R. D. R. F. D. A. Basto, et al.
Published: (2023-03-01)

Gender differences in response and remission rates among patients receiving esketamine
by: A. T. Guterman, et al.
Published: (2023-03-01)

Early real-life evaluation of the efficacy of esketamine in resistant depressive disorder
by: S. Faisant, et al.
Published: (2022-06-01)

Anosmia and ageusia after intravenous esketamine and propofol-based general anesthesia
by: Cunjin Wang, et al.
Published: (2023-11-01)

Esketamine improves propofol-induced brain injury and cognitive impairment in rats
by: Xu Guiping, et al.
Published: (2022-12-01)

Esketamine prevents propofol-induced injection pain: Randomized controlled trial
by: Chaozhi Xu, et al.
Published: (2022-09-01)

Heterogeneous trajectory of depressive symptoms after repeated subcutaneous esketamine injections
by: Matheus Ghossain Barbosa, et al.
Published: (2021-01-01)

Esketamine may be an ideal substitute for ketamine during cochlear function measurement
by: Yufeng Li, et al.
Published: (2021-08-01)

Meta-analysis of epigenome-wide association studies of major depressive disorder
by: Qingqin S. Li, et al.
Published: (2022-11-01)

The efficacy and safety of esketamine in pediatric anesthesia: A systematic review and meta-analysis
by: Bin-Sen Zhang, et al.
Published: (2023-12-01)

Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality
by: Dong-Jing Fu, et al.
Published: (2023-08-01)

Esketamine Inhibits Cocaine-Seeking Behaviour Subsequent to Various Abstinence Conditions in Rats
by: Karolina Wydra, et al.
Published: (2023-09-01)

Clinical stability after compassionate use of intranasal esketamine in treatment-resistant depression
by: D. Hernandez Huerta, et al.
Published: (2022-06-01)